Digital Edition

Abstracts Presented at the 2018 AVAHO Annual Meeting

September 28-30, 2018 ► Chicago, IL

Fed Pract. 2018 August;35(suppl)

 

Table of Contents

Recommended Reading

Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy? (FULL)
Federal Practitioner
Open Clinical Trials for Patients With Renal Cell Carcinoma (FULL)
Federal Practitioner
Immunotherapies shape the treatment landscape for hematologic malignancies
Federal Practitioner
Former Smokers Motivate Quitters
Federal Practitioner
Colorectal cancer: New observations, new implications
Federal Practitioner
VA and NCI Join to Provide Leading-Edge Cancer Treatment
Federal Practitioner
FDA warns against azithromycin in blood or lymph node cancers
Federal Practitioner
New chronic lymphocytic leukemia guidelines from the UK
Federal Practitioner
Advances in Hematology and Oncology (August 2018)
Federal Practitioner
Could An Antibiotic Be the Next Great Oncologic Drug?
Federal Practitioner